Le Lézard
Classified in: Environment, Transportation, Science and technology

Hyundai Motor Group Increases US Investment as the Group Targets Innovation and Mobility Leadership


SEOUL, South Korea, May 23, 2022 /CNW/ -- Hyundai Motor Group (HMG) is increasing its investment to more than USD 10 billion by 2025 to further its goal to lead sustainable and smart mobility solutions in the U.S.

Euisun Chung, Executive Chair of Hyundai Motor Group, following his meeting with U.S. President Joe Biden in Seoul on May 22nd, announced the Group's plan to invest more than USD 10 billion in US by 2025 to lead future mobility solutions.

 

The Group's investment plans are designed to accelerate innovation and mobility electrification. The move supports carbon neutrality goals with new technologies and will contribute to manufacturing in the U.S.

"We have come a long way and become very successful in a short period of time, but we are also preparing for our future," said Euisun Chung, Executive Chair of Hyundai Motor Group, following his meeting with U.S. President Joe Biden in Seoul on May 22nd. "The Group will strengthen our partnership with U.S. public and private entities to offer innovative products and mobility solutions to our valued customers in the U.S. while supporting global carbon neutrality efforts," added Chung.

This follows the announcement last week in which Hyundai Motor Group disclosed a USD 5.54 billion plan to establish its first dedicated U.S. EV and battery manufacturing facilities in the State of Georgia to build a wide range of innovative electric vehicles for its U.S. customers.

The new facility, located on a dedicated 2,923-acre site in Bryan County, Georgia, will break ground in early 2023 and is expected to begin commercial production in the first half of 2025 with an annual capacity of 300,000 units. The new facility will help HMG lead the U.S. auto market's EV transition and the Group's roadmap to be one of top three EV providers in the U.S. by 2026, helping to grow U.S. innovation and manufacturing.

The new plant will implement many of HMG's advanced intelligent manufacturing technologies, boasting a highly connected, automated, and flexible manufacturing system, which organically connects all elements of the EV ecosystem to realize customer value. As part of the Group's commitment to sustainability, the plant will mainly rely on renewable energy sources to power the facility and use emission-reduction technologies to meet the RE100 requirements. 

As one of the global leaders in innovation, HMG has allocated a series of additional expenditure to foster key future businesses such as robotics, advanced air mobility (AAM), autonomous driving, and artificial intelligence (AI). The investment will enable HMG to offer diverse mobility products and services with greater safety and convenience.

SOURCE Hyundai Motor Group


These press releases may also interest you

at 12:30
New data presented in two separate oral presentations at the European Association for the Study of the Liver's International Liver Congress 2022 (EASL ILC 2022)Following 90 days of dosing, ATI-2173, in combination with tenofovir disoproxil fumarate...

at 09:05
Ionis Pharmaceuticals, Inc. , today...

at 06:15
Using Verv, business customers in Europe can open a digital bank account with its unique IBAN ? International Bank Account Number ? for standardised banking services worldwide. This is the international equivalent of Australia's BSB system but on a...

at 04:25
The San Francisco Deputy Sheriffs' Association wrote a letter to San Francisco Mayor London Breed and requested that she intervene to force the San Francisco Sheriff's Office to increase hiring. SFDSA President Ken Lomba stated, "We have been...

at 03:00
Global digital assets exchange PayBito promotes crypto trade through trading bots. PayBito chief and blockchain pioneer Raj Chowdhury supports the use of trading bots recalling the theory that blockchain was designed to be "trustless". The theory...

at 00:35
Sinovac Biotech Ltd. ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that the South African Health Products Regulatory Authority (SAHPRA) granted conditional registration to SINOVAC CoronaVac®...



News published on 23 may 2022 at 08:00 and distributed by: